BridgeBio careers

We ultimately exist to help patients. millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. we are committed to bridging this gap: between business case and scientific possibility, between patient and hope. this starts with our first core value: put patients first